Tilray Brands (TLRY) Interest & Investment Income (2017 - 2026)
Tilray Brands (TLRY) reported Interest & Investment Income of -$5.0 million for Q1 2026, up 40.74% on a YoY basis from -$3.5 million in Q1 2025, and up 7.61% quarter-over-quarter from -$5.4 million in Q4 2025.
Tilray Brands (TLRY) Interest & Investment Income (2017 - 2026) Analysis & Trends
Tilray Brands has reported Interest & Investment Income for 10 years, with the latest figure at -$5.0 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 40.74% year-over-year to -$5.0 million; the trailing twelve-month figure through Feb 2026 stood at $20.3 million (up 157.36% YoY), and the FY2025 full-year result was $11.4 million, up 131.23% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$5.0 million, up from -$5.4 million in the prior quarter.
- The five-year high for Interest & Investment Income was $37.4 million in Q2 2025, with the low at -$9.8 million in Q3 2024.
- Historically, Interest & Investment Income has averaged -$1.4 million across 5 years, with a median of -$5.4 million in 2025.
- Annual changes were most pronounced in 2024 — Interest & Investment Income slumped 718.94% — and 2025, when it soared 495.15%.
- Tilray Brands' Interest & Investment Income stood at -$3.1 million in 2022, then slumped by 177.6% to -$8.6 million in 2023, then grew by 9.96% to -$7.8 million in 2024, then jumped by 30.8% to -$5.4 million in 2025, then rose by 7.61% to -$5.0 million in 2026.
- The last three Interest & Investment Income figures came in at -$5.0 million (Q1 2026), -$5.4 million (Q4 2025), and -$6.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Tilray Brands | - | - | 54.95 Mn | -4.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -4.97 Mn |
| Nov 30, 2025 | -5.37 Mn |
| Aug 31, 2025 | -6.70 Mn |
| May 31, 2025 | 37.37 Mn |
| Feb 28, 2025 | -8.38 Mn |
| Nov 30, 2024 | -7.77 Mn |
| Aug 31, 2024 | -9.84 Mn |
| May 31, 2024 | -9.46 Mn |
| Feb 29, 2024 | -8.52 Mn |
| Nov 30, 2023 | -8.63 Mn |
| Aug 31, 2023 | -9.84 Mn |
| May 31, 2023 | -5.03 Mn |
| Feb 28, 2023 | -1.04 Mn |
| Nov 30, 2022 | -3.11 Mn |
| Aug 31, 2022 | -4.41 Mn |
| May 31, 2022 | 34.16 Mn |
| Feb 28, 2022 | -2.31 Mn |
| Nov 30, 2021 | -9.94 Mn |
| Aug 31, 2021 | -10.17 Mn |
| May 31, 2021 | -9.47 Mn |